Get startedLog in
    Picture of Sequana Medical NV logo

    SEQUA — Sequana Medical NV News Story

    0.000.00%
    be flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro Cap
    All News

    Brief: Sequana Medical Announces First Patient Enrolled In U.S. Randomized Controlled Phase 1/2A Study Of Congestive Heart Failure Treatment

    Picture of Sequana Medical NV logoSequana Medical NV
    10/07/2023 06:18
    July 10 (Reuters) - Sequana Medical NV  SEQUA.BR :
    * SEQUANA MEDICAL ANNOUNCES FIRST PATIENT ENROLLED IN
MOJAVE, A US
RANDOMIZED CONTROLLED PHASE 1/2A STUDY OF DSR® 2.0 FOR TREATMENT
OF CONGESTIVE HEART FAILURE
    * INITIAL DATA EXPECTED IN Q4 2023

Source text for Eikon:  ID:nGNX6RCgTL 
Further company coverage:  SEQUA.BR 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com ; +48 58 769 66 00;))

    Recent news on Sequana Medical NV

    See all news